SCLX
Scilex Holding Company
NASDAQ: SCLX · HEALTHCARE · DRUG MANUFACTURERS - GENERAL
$10.52
+21.76% today
Updated 2026-04-30
Market cap
$47.05M
P/E ratio
—
P/S ratio
1.56x
EPS (TTM)
$-36.48
Dividend yield
—
52W range
$4 – $34
Volume
0.0M
Scilex Holding Company (SCLX) Financial statements
SEC filings — annual and quarterly data.
Balance sheet — annual
| Item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|
| Total assets | — | $81.50M | $77.93M | $86.53M | $101.31M | $92.95M |
| Cash & equivalents | — | $4.84M | $4.34M | $2.18M | $3.92M | $3.27M |
| Current assets | — | $22.42M | $23.00M | $29.61M | $46.78M | $41.55M |
| Total liabilities | — | $223.19M | $301.81M | $50.29M | $274.25M | $285.59M |
| Current liabilities | — | $78.48M | $169.42M | $44.84M | $250.38M | $259.63M |
| Long-term debt | — | $107.66M | $3.83M | — | $17.04M | $845000.00 |
| Shareholder equity | — | $-141.68M | $-223.88M | $36.24M | $-172.94M | $-192.64M |
| Retained earnings | — | $-264.13M | $-352.55M | $-375.91M | $-490.25M | $-563.05M |
| Accounts receivable | — | $13.13M | $14.27M | $21.24M | $34.60M | $26.44M |
| Inventory | — | $1.15M | $2.56M | $1.38M | $4.21M | $2.44M |
| Goodwill | — | $13.48M | $13.48M | $13.48M | $13.48M | $13.48M |